| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $81.0M | -24.6% |
| Cost of Revenue | $26.4M | -35.2% |
| Gross Profit | $54.6M | -18.1% |
| R&D Expense | $2.8M | -31.8% |
| SG&A Expense | $22.5M | -21.4% |
| Operating Income | -$5.3M | +69.2% |
| Pre-tax Income | -$14.1M | +17.4% |
| Income Tax | $1.8M | — |
| Net Income | -$15.8M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | -13.0% |
| Accounts Receivable | $23.6M | -18.4% |
| Inventory | $12.6M | +5.3% |
| Total Assets | $118.1M | -13.5% |
| Current Liabilities | $62.2M | -9.8% |
| Long-term Debt | $10.9M | -27.5% |
| Stockholders' Equity | $27.7M | -29.6% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.4M | +72.9% |
| Investing Cash Flow | -$329K | -181.2% |
| Financing Cash Flow | -$1.3M | -114.2% |
| +7.1% |
| EPS (Basic) | -$2.86 | +44.0% |